... Dec 08
As per the British government, the shots will be initially available at hospitals before distributing stocks to doctors' clinics... Dec 08
Through collaboration companies will leverage Pfizer's extensive data and experience with PostEra's technological resources to promote the science of generative chemistry... Dec 08
If approved, Nucala would be the only treatment approved in the US for use in four eosinophil-driven diseases. ... Dec 08
Effective January 1, 2021, Anil Soni will become CEO of the WHO Foundation... Dec 08
The deal would combine the expertise of both companies and result in synergies that will bring in greater operational capabilities to enhance FBL’s footprint ... Dec 08
The company plans to begin a Phase 1/2 clinical trial of KB-0742 in patients with advanced solid tumours in the first quarter of ... Dec 08
Heightened risk ranges from 50% to 285% by the age of 18; depression severity greater in boys... Dec 08
-Advertisements-
Friday, May 03, 2024
.jpeg)
